MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, NXTC had -$1,745K decrease in cash & cash equivalents over the period.

Cash Flow Overview

Change in Cash
-$1,745K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Sales and maturities of marketab...
    • Proceeds from issuance of common...
    • Accrued liabilities and other li...
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Purchases of marketable securiti...
    • Accounts payable
    • Others

Cash Flow
2025-12-31
Net loss
-55,844
Depreciation and amortization
2,185
Amortization of premiums and discounts on marketable securities
481
Stock-based compensation
2,986
Noncash operating lease expense
587
Prepaid expenses and other assets
-1,102
Accounts payable
-3,342
Accrued liabilities and other liabilities
-4,334
Lease liabilities
-1,005
Other long-term liabilities
-135
Net cash used in operating activities
-49,613
Sales and maturities of marketable securities
52,261
Purchases of marketable securities
26,705
Net cash provided by investing activities
25,556
Proceeds from issuance of common stock
22,276
Proceeds from shares issued under espp
36
Net cash provided by financing activities
22,312
Net increase (decrease) in cash and cash equivalents
-1,745
Cash and cash equivalents - beginning of period
27,727
Cash and cash equivalents - end of period
25,982
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Sales and maturitiesof marketable...$52,261K Proceeds from issuance ofcommon stock$22,276K Proceeds from sharesissued under espp$36K Net cash provided byinvesting activities$25,556K Net cash provided byfinancing activities$22,312K Canceled cashflow$26,705K Net increase(decrease) in cash and cash...-$1,745K Canceled cashflow$47,868K Accrued liabilities andother liabilities-$4,334K Stock-based compensation$2,986K Depreciation andamortization$2,185K Prepaid expenses andother assets-$1,102K Noncash operating leaseexpense$587K Purchases of marketablesecurities$26,705K Net cash used inoperating activities-$49,613K Canceled cashflow$11,194K Net loss-$55,844K Accounts payable-$3,342K Lease liabilities-$1,005K Amortization of premiums anddiscounts on marketable...$481K Other long-termliabilities-$135K

NextCure, Inc. (NXTC)

NextCure, Inc. (NXTC)